Generation Bio Co. Profile Avatar - Palmy Investing

Generation Bio Co.

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuse…

Biotechnology
US, Cambridge [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Generation Bio Co. has no acquisition track records yet.

M&A Deals · History

Generation Bio Co. has no acquisition track records yet.

End of GBIO's Analysis
CIK: 1733294 CUSIP: 37148K100 ISIN: US37148K1007 LEI: - UEI: -
Secondary Listings
GBIO has no secondary listings inside our databases.